JV-MD2

N/A

Report date: 2022/08/29 18:02:22

Base Information

Drug NameJV-MD2
Drug Alias NameJV-MD2
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinopathy of PrematurityMacular DegenerationXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJeniVision Inc
China Registration ClassN/A

Develop Information

Active CompaniesJeniVision Inc
Inactive CompaniesN/A
Active IndicationsRetinopathy of PrematurityMacular DegenerationXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A